Diagnosis and therapy of autoimmune liver disease

Medical Clinics of North America

Volumn 80, Issue 5, 1996, Pages 973-994

  Czaja, A J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BREQUINAR; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PHOSPHATIDYLCHOLINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMUS HORMONE; TIMONACIC ARGININE; URSODEOXYCHOLIC ACID;

ACNE; AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOASSAY; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0029757986     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70476-4     Document Type: Article

References (100)

1. N. Abuaf C. Johanet P. Chretien Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis Hepatology 16 1992 892
2. J.S. Amontree T.D. Stuart J.E. Bredfeldt Autoimmune chronic active hepatitis masquerading as acute hepatitis J Clin Gastroenterol 11 1989 303
3. N. Bach S.N. Thung F. Schaffner The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis Hepatology 15 1992 572
4. M.C. Bateson Ursodeoxycholic acid therapy in chronic active hepatitis Postgrad Med J 66 1990 781
5. A.G. Bearn H.G. Kunkel R.J. Slater The problem of chronic liver disease in young women Am J Med 21 1956 3
6. J. Brown S. Dourakis P. Karayiannis Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease Hepatology 15 1992 175
7. L.J. Burgart K.P. Batts J. Ludwig Recent onset autoimmune hepatitis: Biopsy findings and clinical correlations Am J Surg Pathol 19 1995 699
8. F. Carmassi R. Morale R. Puccetti Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis Clin Exp Rheumatol 10 1992 13
9. G.C. Cook R. Mulligan S. Sherlock Controlled prospective trial of corticosteroid therapy in active chronic hepatitis Q J Med 40 1971 159
10. W.G.E. Cooksley R.A. Bradbear W. Robinson The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis Hepatology 6 1986 345
11. R.M. Crapper P.S. Bhathal I.R. Mackay “Acute” autoimmune hepatitis Digestion 34 1986 216
12. A. Crosignani P.M. Battezzati K.D.R. Setchell Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: A dose-response study Hepatology 13 1991 339
13. A.J. Czaja Autoimmune chronic active hepatitis-a specific entity? The negative argument J Gastro Hepatol 5 1990 343
14. A.J. Czaja Autoimmune hepatitis and viral infection Gastroenterol Clin North Am 23 1994 547
15. A.J. Czaja Autoimmune hepatitis: Current therapeutic concepts Clin Immunother 1 1994 413
16. A.J. Czaja Autoimmune hepatitis: Evolving concepts and treatment strategies Dig Dis Sci 40 1995 435
17. A.J. Czaja Chronic active hepatitis: The challenge for a new nomenclature Ann Intern Med 119 1993 510
18. A.J. Czaja Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis E.L. Krawitt R.H. Wiesner Autoimmune Liver Disease 1991 Raven Press New York 143
19. A.J. Czaja Low dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis Hepatology 11 1990 1044
20. A.J. Czaja Natural history, clinical features, and treatment of autoimmune hepatitis Semin Liver Dis 4 1984 1
21. A.J. Czaja H.V. Ammon W.H.J. Summerskill Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission Gastroenterology 78 1980 518
22. A.J. Czaja S.J. Beaver M.T. Shiels Sustained remission following corticosteroid therapy of severe HBsAg-negative chronic active hepatitis Gastroenterology 92 1987 215
23. A.J. Czaja H.A. Carpenter Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis Gastroenterology 105 1993 1824
24. A.J. Czaja H.A. Carpenter Validation of a scoring system for the diagnosis of autoimmune hepatitis [abstr] Gastroenterology 108 1995 A1056
25. A.J. Czaja H.A. Carpenter M.P. Manns Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis Gastroenterology 105 1993 1522
26. A.J. Czaja H.A. Carpenter P.J. Santrach Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States J Hepatol 18 1993 342
27. A.J. Czaja H.A. Carpenter P.J. Santrach Genetic predispositions for the immunological features of chronic active hepatitis Hepatology 18 1993 816
28. A.J. Czaja H.A. Carpenter P.J. Santrach The nature and prognosis of severe cryptogenic chronic active hepatitis Gastroenterology 104 1993 1755
29. A.J. Czaja G.L. Davis J. Ludwig Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology Gastroenterology 85 1983 713
30. A.J. Czaja G.L. Davis J. Ludwig Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis Hepatology 4 1984 622
31. A.J. Czaja J.E. Hay J. Rakela Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis Mayo Clin Proc 65 1990 23
32. A.J. Czaja J. Ludwig A.H. Baggenstoss Corticosteroid-treated chronic active hepatitis in remission: Uncertain prognosis of chronic persistent hepatitis N Engl J Med 304 1981 5
33. A.J. Czaja S. Magrin C. Fabiano Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis Dig Dis Sci 40 1995 33
34. A.J. Czaja M.P. Manns H.A. Homburger Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis Gastroenterology 103 1992 1290
35. A.J. Czaja M.P. Manns The validity and importance of subtypes of autoimmune hepatitis: A point of view Am J Gastroenterol 90 1995 1206
36. A.J. Czaja J. Rakela J. Ludwig Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis Gastroenterology 95 1988 448
37. A.J. Czaja H.F. Taswell J. Rakela Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis Gastroenterology 102 1992 1675
38. A.J. Czaja H.F. Taswell J. Rakela Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis Mayo Clin Proc 66 1991 572
39. A.J. Czaja A.M. Wolf A.H. Baggenstoss Laboratory assessment of severe chronic active liver disease (CALD): Correlation of serum transaminase and gamma globulin levels with histologic features Gastroenterology 80 1981 687
40. A. Danielsson H. Prytz Oral budesonide for treatment of autoimmune chronic active hepatitis Aliment Pharmacol Ther 8 1994 585
41. G.L. Davis A.J. Czaja J. Ludwig Development and prognosis of histologic cirrhosis in corticosteroid-treated HBsAg-negative chronic active hepatitis Gastroenterology 87 1984 1222
42. J. DeGroote J. Fevery L. Lepoutre Long-term follow-up of chronic active hepatitis of moderate severity Gut 19 1978 510
43. V.J. Desmet M. Gerber J.H. Hoofnagle Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1994 1513
44. M.G. Geall L.J. Schoenfield W.H.J. Summerskill Classification and treatment of chronic active liver disease Gastroenterology 63 1972 458
45. M. Greeve L. Ferrell M. Kim Cirrhosis of undefined pathogenesis: Absence of evidence for unknown viruses or autoimmune processes Hepatology 17 1993 593
46. M. Gueguen M. Meunier-Rotival O. Bernard Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily J Exp Med 168 1988 801
47. S. Han M. Tredger G.V. Gregorio Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease Hepatology 21 1995 58
48. J.E. Hegarty K.T. Nouri-Aria A.L.W.F. Eddleston Controlled trial of a thymic hormone extract (Thymostimulin) in “autoimmune” chronic active hepatitis Gut 25 1984 279
49. J.E. Hegarty K.T. Nouri-Aria B. Portmann Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis Hepatology 3 1983 685
50. J.-C. Homberg N. Abuaf O. Bernard Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis Hepatology 7 1987 1333
51. J.S. Hyams M. Ballow A.M. Leichtner Cyclosporine treatment of autoimmune chronic active hepatitis Gastroenterology 93 1987 890
52. International Working Party Terminology of chronic hepatitis Am J Gastroenterol 90 1995 181
53. L.J. Jeffers F. Hasan M. De Medina Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis Hepatology 15 1992 187
54. P.J. Jenkins B.P. Portmann A.L.W.F. Eddleston Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: Results of prospective double-blind controlled trial Liver 2 1982 77
55. P.J. Johnson I.G. McFarlane F. Alvarez Meeting Report: International Autoimmune Hepatitis Group Hepatology 18 1993 998
56. M.J. Kemeny G. O'Hanlon P.B. Gregory Asymptomatic chronic active hepatitis— prognosis and treatment [abstr] Gastroenterology 86 1984 1325
57. M. Lenzi P. Manotti L. Muratori Diagnostic relevance of LC1 antigen-antibody system in autoimmune hepatitis type 2 J Hepatol 18 suppl 1993 S7
58. Y. Liaw C. Chu T. Chen Chronic lobular hepatitis: A clinicopathological and prognostic study Hepatology 2 1982 258
59. K. Lidman G. Biberfield A. Fagraeus Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis Clin Exp Immunol 24 1976 266
60. J. Loeper V. Descatoire M. Maurice Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies Gastroenterology 104 1993 203
61. H. Lohr M. Manns A. Kyriatsoulis Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis Clin Exp Immunol 84 1991 297
62. J. Ludwig Members of the Working Party of the World Congresses of Gastroenterology Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: Summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994 Am J Gastroenterol 89 1994 S177
63. W.C. Maddrey Subdivisions of idiopathic autoimmune chronic active hepatitis Hepatology 7 1987 1372
64. M. Manns G. Gerken A. Kyriatsoulis Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen Lancet 1 1987 292
65. M. Manns U. Zanger G. Gerken Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db 1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo Hepatology 12 1990 127
66. M.P. Manns K.J. Griffin K.F. Sullivan LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase J Clin Invest 88 1991 1370
67. M.P. Manns E.F. Johnson K.J. Griffin Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1 J Clin Invest 83 1989 1066
68. E. Martini N. Abuaf F. Cavalli Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2 Hepatology 8 1988 1662
69. I.G. McFarlane J.E. Hegarty C.G. McSorley Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis Lancet 2 1984 954
70. I.G. McFarlane H.M. Smith P.J. Johnson Hepatitis C virus antibodies in chronic active hepatitis: Pathogenetic factor or false-positive result? Lancet 335 1990 754
71. G.Y. Minuk Cyclosporin A in nontransplant-related liver disease Am J Gastroenterol 84 1989 1345
72. A. Miracco G. Iodice C. Peluso Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: Double-blind comparison with placebo J Int Med Res 12 1984 35
73. S.P. Mistilis C.R. Vickers M.H. Darroch Cyclosporin, a new treatment for autoimmune chronic active hepatitis Med J Aust 143 1985 463
74. I.M. Murray-Lyon R.B. Stern R. Williams Controlled trial of prednisone and azathioprine in active chronic hepatitis Lancet 1 1973 735
75. J. Neuberger J.E. Hegarty A.L.W.F. Eddleston Effect of polyunsaturated phosphatidylcholine on immune mediated hepatocyte damage Gut 24 1983 751
76. J. Neuberger B. Portmann R. Calne Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting Transplantation 37 1984 363
77. G.A. Nikias K.P. Batts A.J. Czaja The nature and prognostic implications of autoimmune hepatitis with an acute presentation J Hepatol 21 1994 866
78. R. Perdigoto H.A. Carpenter A.J. Czaja Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis J Hepatol 14 1992 325
79. H. Popper F. Schaffner The vocabulary of chronic hepatitis [edit] N Engl J Med 284 1971 1154
80. T. Poralla U. Treichel H. Lohr The asialoglycoprotein receptor as target structure in autoimmune liver diseases Semin Liver Dis 11 1991 215
81. G. Porta L.C. Da Costa Gayotto F. Alvarez Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure J Pediatr Gastroenterol Nutr 11 1990 138
82. M. Rabinovitz A.J. Demetris C.F. Bou-Abboud Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis Dig Dis Sci 37 1992 1606
83. S.K. Roberts T. Therneau A.J. Czaja Histologic cirrhosis before or after corticosteroid therapy does not affect treatment response or survival in type 1 autoimmune hepatitis [abstr] Gastroenterology 108 1995 A1156
84. L. Sanchez-Urdazpal A.J. Czaja B. van Hoek Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis Hepatology 15 1992 215
85. S.W. Schalm H.V. Ammon W.H.J. Summerskill Failure of customary treatment in chronic active liver disease: Causes and management Ann Clin Res 8 1976 221
86. S.W. Schalm M.G. Korman W.H.J. Summerskill Severe chronic active liver disease: Prognostic significance of initial morphologic patterns Am J Dig Dis 22 1977 973
87. L.B. Seeff Drug-induced chronic liver disease, with emphasis on chronic active hepatitis Semin Liver Dis 1 1981 104
88. R.D. Soloway W.H.J. Summerskill A.H. Baggenstoss Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis Gastroenterology 63 1972 820
89. E. Stechemesser R. Klein P.A. Berg Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis Hepatology 18 1993 1
90. A.J. Stellon J.J. Keating P.J. Johnson Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal Hepatology 8 1988 781
91. W.H.J. Summerskill M.G. Korman H.V. Ammon Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared Gut 16 1975 876
92. A.W. Thomson P.B. Carroll J. McCauley FK 506: A novel immunosuppressant for treatment of autoimmune disease: Rationale and preliminary clinical experience at the University of Pittsburgh Springer Semin Immunopathol 14 1993 323
93. C. Trautwein G. Ramadori G. Gerkin Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice Biochem Biophys Res Commun 182 1992 617
94. D.H. Van Thiel H. Wright P. Carroll FK 506 in the treatment of autoimmune chronic active hepatitis: Preliminary results [abstr] Am J Gastroenterol 87 1992 1309
95. B. Wachter A. Kyriatsoulis A.W. Lohse Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies J Hepatol 11 1990 232
96. K.K. Wang A.J. Czaja S.J. Beaver Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis Hepatology 10 1989 39
97. S.P. Wilkinson B. Portmann A.M.G. Cochrane Clinical course of chronic lobular hepatitis Q J Med 47 1978 421
98. H.L. Wright C.F. Bou-Abboud T. Hassanein Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease Transplantation 53 1992 136
99. A.M. Yamamoto D. Cresteil J.C. Homberg Characterization of the anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera Gastroenterology 104 1993 1762
100. U.M. Zanger H.-P. Hauri J. Loeper Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II Proc Natl Acad Sci 85 1988 8256